Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Sex Hormone Receptors in Benign and Malignant Salivary Gland Tumors: Prognostic and Predictive Role.

Aquino G, Collina F, Sabatino R, Cerrone M, Longo F, Ionna F, Losito NS, De Cecio R, Cantile M, Pannone G, Botti G.

Int J Mol Sci. 2018 Jan 30;19(2). pii: E399. doi: 10.3390/ijms19020399.

2.

[Parotid metastasis from carcinoma of the breast: report of a case and review of the literature].

El M'rabet F, Kanab R, Ameuraoui T, Sidibe F, Azegrare M, Arifi S, El Maaroufi M, Amarti A, Mellas N.

Pan Afr Med J. 2017 Jun 2;27:79. doi: 10.11604/pamj.2017.27.79.8876. eCollection 2017. Review. French.

3.

Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.

Udager AM, Chiosea SI.

Head Neck Pathol. 2017 Sep;11(3):288-294. doi: 10.1007/s12105-017-0798-x. Epub 2017 Mar 20.

4.

AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.

Schweizer MT, Yu EY.

Cancers (Basel). 2017 Jan 11;9(1). pii: E7. doi: 10.3390/cancers9010007. Review.

5.

Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.

Otsuka K, Imanishi Y, Tada Y, Kawakita D, Kano S, Tsukahara K, Shimizu A, Ozawa H, Okami K, Sakai A, Sato Y, Ueki Y, Sato Y, Hanazawa T, Chazono H, Ogawa K, Nagao T.

Ann Surg Oncol. 2016 Jun;23(6):2038-45. doi: 10.1245/s10434-015-5082-2. Epub 2016 Jan 20.

6.

Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.

Mitani Y, Rao PH, Maity SN, Lee YC, Ferrarotto R, Post JC, Licitra L, Lippman SM, Kies MS, Weber RS, Caulin C, Lin SH, El-Naggar AK.

Clin Cancer Res. 2014 Dec 15;20(24):6570-81. doi: 10.1158/1078-0432.CCR-14-1746. Epub 2014 Oct 14.

7.

Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature.

Kuo YJ, Weinreb I, Perez-Ordonez B.

Head Neck Pathol. 2013 Jul;7 Suppl 1:S59-67. doi: 10.1007/s12105-013-0460-1. Epub 2013 Jul 3. Review.

8.

Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Simpson RH.

Head Neck Pathol. 2013 Jul;7 Suppl 1:S48-58. doi: 10.1007/s12105-013-0456-x. Epub 2013 Jul 3. Review.

9.

Immunohistochemical analysis of salivary gland tumors: application for surgical pathology practice.

Nagao T, Sato E, Inoue R, Oshiro H, H Takahashi R, Nagai T, Yoshida M, Suzuki F, Obikane H, Yamashina M, Matsubayashi J.

Acta Histochem Cytochem. 2012 Oct 31;45(5):269-82. doi: 10.1267/ahc.12019. Epub 2012 Sep 22.

10.

Invasive salivary duct carcinoma ex pleomorphic adenoma of the parotid gland: a teaching case giving rise to the genuine diagnostic difficulty on an inadequate cytology specimen.

Yamada S, Nabeshima A, Tabata T, Guo X, Tasaki T, Wang KY, Shimajiri S, Sasaguri Y.

Diagn Pathol. 2012 May 30;7:61. doi: 10.1186/1746-1596-7-61.

11.

Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.

Murase R, Sumida T, Ishikawa A, Murase R, McAllister SD, Hamakawa H, Desprez PY.

Int J Otolaryngol. 2011;2011:187623. doi: 10.1155/2011/187623. Epub 2011 Nov 21.

12.
13.

Supplemental Content

Support Center